<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03146156</url>
  </required_header>
  <id_info>
    <org_study_id>IRB16-00553</org_study_id>
    <secondary_id>R01HD088061</secondary_id>
    <nct_id>NCT03146156</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention in Preparation for Pregnancy (LIPP)</brief_title>
  <official_title>Lifestyle Intervention in Preparation for Pregnancy (LIPP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>MetroHealth Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this proposal is to break the vicious cycle of obesity/metabolic dysfunction
      during pregnancy. Lifestyle interventions in obese women during pregnancy have had limited
      success in improving maternal or offspring short and long-term metabolic health. We propose
      that lifestyle interventions need to be initiated prior to conception in overweight and obese
      women (henceforth referred to as obese) in order to first improve maternal metabolism.
      Lifestyle interventions will take place in the greater Cleveland recreational facilities.
      Metabolic evaluations will be conducted in the Clinical Research Units of the Case Western
      Reserve Clinical Translational Science Center (CTSC). We hypothesize this will result in
      decreased fetal adiposity and improved metabolic function in the offspring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aim 1: To investigate the physiological significance of lifestyle intervention in
      preparation for pregnancy (LIPP) on maternal and neonatal metabolism and adiposity.

      We will recruit mothers who delivered their first baby at MHMC. We will conduct the exercise
      sessions in local Community Recreation Centers. We will provide childcare and we will support
      the cost so participants may bring their babies to the LIPP sessions.

      The LIPP program is designed to promote weight loss that is 5-10% of current body weight. The
      3-month weight loss phase consists of aerobic exercise training with diet and behavioral
      counseling to induce weight loss as was successfully achieved in prior studies. The women
      will wear heart rate (HR) monitors (Polar Electro, Woodbury, NY) during each exercise session
      so that they have visual feedback of their personalized target heart rate goal. Our Lifestyle
      Coaches will enter all foods eaten into our diet database (NDSR, Minneapolis, MN) to
      facilitate analysis of calorie, and macro/micro nutrient intake. Subjects will generate
      photos from before and after the meal in order to estimate the amount of food that was eaten.
      Data will be obtained at baseline, and at 2-week intervals during the initial 12-week
      supervised weight loss period.

      Lifestyle Intervention - Weight Management/Maintenance:

      The pre-pregnancy weight management program (Phases 2A, 2B and 2C) is designed to facilitate
      personalized weight loss goals using lifestyle behaviors that include, exercise, diet and
      behavioral modification. The intervention includes a &quot;toolbox&quot; concept to help meet weight
      loss goals. The Lifestyle Coaches will provide personalized instruction on physical
      activity/exercise. Participants randomized to the Control group will receive information on
      post-pregnancy diet/weight loss from the nutritionist as distinct from the LIPP nutritionist
      to decrease cross contamination between groups.

      Weight Management during Pregnancy:

      All LIPP and usual care/control groups will be followed by their primary Obstetrical
      provider. The OB/GYN department at MHMC has recently revised its clinical guidelines for the
      management of the overweight/obese women based on the December 2015 ACOG practice bulletin.
      All overweight/obese women will be offered nutrition counseling early in pregnancy by a
      registered dietician from the MHMC Nutrition Department with follow-up visits as needed to
      support GWG within the IOM guidelines. The Lifestyle Coach will continue to follow-up only
      with the LIPP subjects as described in the maintenance phase of the research design.

      Specific Aim 2: To determine the molecular effects whereby lifestyle intervention initiated
      before pregnancy can improve placental mitochondrial lipid oxidation and accumulation

      We will accomplish the objectives of Specific Aim 2 by measuring changes in placental
      mitochondrial enzyme activity and lipid metabolism in women enrolled in the Control or LIPP
      groups described in Specific Aim 1. Placental tissue will be collected at delivery from all
      study participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal adiposity comparison between intervention and usual care group</measure>
    <time_frame>48 to 72 hours after delivery</time_frame>
    <description>Neonatal anthropometry and air densitometry (pea pod)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal metabolic status</measure>
    <time_frame>from baseline to 6 month post-partum and then during pregnancy at 12 to 16 weeks gestation and 34 to 36 weeks gestation.</time_frame>
    <description>body composition, insulin sensitivity and insulin response</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Obesity</condition>
  <condition>Lifestyle-related Condition</condition>
  <condition>Macrosomia, Fetal</condition>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lifestyle coaches will provide personalized instruction on physical activity, dietary data, and behavioral strategies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The usual care/control groups will be followed by their primary Obstetrical provider. All overweight/obese women will be offered nutrition counseling early in pregnancy by a registered dietician to support GWG within the IOM guidelines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Intervention</intervention_name>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planning another pregnancy within the next 24 months

          -  Planning to deliver at MetroHealth Medical Center during their next pregnancy

          -  A previous full-term singleton pregnancy (gestational age &gt; 37 weeks)

          -  Vaginal or cesarean delivery

          -  Normal glucose tolerance or gestational diabetes (GDM), but without evidence of
             postpartum diabetes as defined by a 75 g 2-hr oral glucose tolerance test (OGTT)

          -  Normal blood pressure or mild preeclampsia but normal postpartum blood pressure

          -  Bottle or breast feeding

          -  Vaginal or cesarean delivery

          -  Normal thyroid function (determined by TSH concentration in blood), normal cell blood
             count and normal kidney and liver functions. Lipid profile with triglyceride levels
             not higher than 400 mg/dl (fasting) and LDL levels less than 180 mg/dL

          -  No clinical signs or symptoms of cardiovascular disease or any other disease or
             condition that may contraindicate participation in exercise training (i.e. COPD,
             severe asthma, orthopedic abnormalities)

          -  Using contraception

        Exclusion Criteria:

          -  Pre- or post-delivery diabetes

          -  Post-delivery hypertension requiring medication

          -  Asthma requiring more than occasional use of a sympathomimetic inhaler, but not
             chronic inhaled steroids

          -  Inflammatory bowel disease

          -  Need for assisted reproductive technologies to become pregnant

          -  Medical or obstetrical contraindication to the defined exercise program or diet

          -  Tobacco, excessive alcohol use (greater than 2 drinks/day) or illicit drug use

          -  Eating disorders such as bulimia

          -  Gastric surgery to lose weight including banding or bypass procedures

          -  Any psychological or psychiatric condition which may impair participation in the
             lifestyle intervention program

          -  Multiple pregnancy

          -  HIV, or hepatitis B or C

          -  If a LIPP participant becomes pregnant prior to 16 weeks after randomization before
             the weight-loss phase for the lifestyle intervention is completed or a control
             participant becomes pregnant before the 3 month postpartum randomization, i.e. no
             baseline measurement.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>We will recruit a total of 200 overweight/obese subjects (defined as pregravid BMI 25-35 kg/m2) at the time of their first pregnancy, hereafter defined as obese) after delivery of their first child on the postpartum unit of MetroHealth Medical Center (MHMC).</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larraine Presley, MS, RN</last_name>
    <role>Study Director</role>
    <affiliation>Metro Health, Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Axelrod, MS</last_name>
    <role>Study Director</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick M Catalano, MD</last_name>
    <phone>2167784262</phone>
    <email>pcatalano@metrohealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John P Kirwan, PhD</last_name>
    <phone>216-444-3412</phone>
    <email>kirwanj@ccf.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Catalano, MD</last_name>
      <phone>216-778-8462</phone>
      <email>pcatalano@metrohealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Larraine Presley</last_name>
      <phone>2167788927</phone>
      <email>lpresley@metrohealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, de Las Fuentes L, He S, Okunade AL, Patterson BW, Klein S. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab. 2016 Apr 12;23(4):591-601. doi: 10.1016/j.cmet.2016.02.005. Epub 2016 Feb 22.</citation>
    <PMID>26916363</PMID>
  </reference>
  <reference>
    <citation>ACOG Practice Bulletin No 156: Obesity in Pregnancy. Obstet Gynecol. 2015 Dec;126(6):e112-26. doi: 10.1097/AOG.0000000000001211. Erratum in: Obstet Gynecol. 2016 Dec;128(6):1450.</citation>
    <PMID>26595582</PMID>
  </reference>
  <reference>
    <citation>Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med. 2016 Mar 3;374(9):843-52. doi: 10.1056/NEJMsa1506575.</citation>
    <PMID>26962904</PMID>
  </reference>
  <reference>
    <citation>Catalano PM. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol. 2007 Oct;110(4):743-4.</citation>
    <PMID>17906003</PMID>
  </reference>
  <reference>
    <citation>Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39. Epub 2012 Jan 17.</citation>
    <PMID>22253363</PMID>
  </reference>
  <reference>
    <citation>Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012 Feb 1;307(5):483-90. doi: 10.1001/jama.2012.40. Epub 2012 Jan 17.</citation>
    <PMID>22253364</PMID>
  </reference>
  <reference>
    <citation>Ananth CV, Wen SW. Trends in fetal growth among singleton gestations in the United States and Canada, 1985 through 1998. Semin Perinatol. 2002 Aug;26(4):260-7.</citation>
    <PMID>12211616</PMID>
  </reference>
  <reference>
    <citation>Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S. Reasons for increasing trends in large for gestational age births. Obstet Gynecol. 2004 Oct;104(4):720-6.</citation>
    <PMID>15458892</PMID>
  </reference>
  <reference>
    <citation>Catalano PM. Management of obesity in pregnancy. Obstet Gynecol. 2007 Feb;109(2 Pt 1):419-33. Review.</citation>
    <PMID>17267845</PMID>
  </reference>
  <reference>
    <citation>Donahue SM, Kleinman KP, Gillman MW, Oken E. Trends in birth weight and gestational length among singleton term births in the United States: 1990-2005. Obstet Gynecol. 2010 Feb;115(2 Pt 1):357-64. doi: 10.1097/AOG.0b013e3181cbd5f5.</citation>
    <PMID>20093911</PMID>
  </reference>
  <reference>
    <citation>Gibson KS, Waters TP, Gunzler DD, Catalano PM. A retrospective cohort study of factors relating to the longitudinal change in birth weight. BMC Pregnancy Childbirth. 2015 Dec 22;15:344. doi: 10.1186/s12884-015-0777-8.</citation>
    <PMID>26693917</PMID>
  </reference>
  <reference>
    <citation>Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, Maria Siega-Riz A. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol. 2010 Nov;116(5):1191-5. doi: 10.1097/AOG.0b013e3181f60da7. Review.</citation>
    <PMID>20966705</PMID>
  </reference>
  <reference>
    <citation>Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics. 2004 Jul;114(1):e29-36.</citation>
    <PMID>15231970</PMID>
  </reference>
  <reference>
    <citation>Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005 Mar;115(3):e290-6.</citation>
    <PMID>15741354</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009 Nov;90(5):1303-13. doi: 10.3945/ajcn.2008.27416. Epub 2009 Sep 16.</citation>
    <PMID>19759171</PMID>
  </reference>
  <reference>
    <citation>Philipps LH, Santhakumaran S, Gale C, Prior E, Logan KM, Hyde MJ, Modi N. The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis. Diabetologia. 2011 Aug;54(8):1957-66. doi: 10.1007/s00125-011-2180-y. Epub 2011 May 31. Review.</citation>
    <PMID>21626451</PMID>
  </reference>
  <reference>
    <citation>Walsh JM, McGowan CA, Mahony R, Foley ME, McAuliffe FM. Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomised control trial. BMJ. 2012 Aug 30;345:e5605. doi: 10.1136/bmj.e5605.</citation>
    <PMID>22936795</PMID>
  </reference>
  <reference>
    <citation>Vinter CA, Jensen DM, Ovesen P, Beck-Nielsen H, Jørgensen JS. The LiP (Lifestyle in Pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese pregnant women. Diabetes Care. 2011 Dec;34(12):2502-7. doi: 10.2337/dc11-1150. Epub 2011 Oct 4.</citation>
    <PMID>21972411</PMID>
  </reference>
  <reference>
    <citation>Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, Crowther CA, Wittert G, Owens JA, Robinson JS; LIMIT Randomised Trial Group. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014 Feb 10;348:g1285. doi: 10.1136/bmj.g1285.</citation>
    <PMID>24513442</PMID>
  </reference>
  <reference>
    <citation>Phelan S, Phipps MG, Abrams B, Darroch F, Grantham K, Schaffner A, Wing RR. Does behavioral intervention in pregnancy reduce postpartum weight retention? Twelve-month outcomes of the Fit for Delivery randomized trial. Am J Clin Nutr. 2014 Feb;99(2):302-11. doi: 10.3945/ajcn.113.070151. Epub 2013 Nov 27.</citation>
    <PMID>24284438</PMID>
  </reference>
  <reference>
    <citation>Renault KM, Nørgaard K, Nilas L, Carlsen EM, Cortes D, Pryds O, Secher NJ. The Treatment of Obese Pregnant Women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol. 2014 Feb;210(2):134.e1-9. doi: 10.1016/j.ajog.2013.09.029. Epub 2013 Sep 20.</citation>
    <PMID>24060449</PMID>
  </reference>
  <reference>
    <citation>Poston L, Bell R, Croker H, Flynn AC, Godfrey KM, Goff L, Hayes L, Khazaezadeh N, Nelson SM, Oteng-Ntim E, Pasupathy D, Patel N, Robson SC, Sandall J, Sanders TA, Sattar N, Seed PT, Wardle J, Whitworth MK, Briley AL; UPBEAT Trial Consortium. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77. doi: 10.1016/S2213-8587(15)00227-2. Epub 2015 Jul 9.</citation>
    <PMID>26165396</PMID>
  </reference>
  <reference>
    <citation>Sagedal LR, Øverby NC, Bere E, Torstveit MK, Lohne-Seiler H, Småstuen M, Hillesund ER, Henriksen T, Vistad I. Lifestyle intervention to limit gestational weight gain: the Norwegian Fit for Delivery randomised controlled trial. BJOG. 2017 Jan;124(1):97-109. doi: 10.1111/1471-0528.13862. Epub 2016 Jan 14.</citation>
    <PMID>26768233</PMID>
  </reference>
  <reference>
    <citation>Dodd JM, Grivell RM, Crowther CA, Robinson JS. Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials. BJOG. 2010 Oct;117(11):1316-26. doi: 10.1111/j.1471-0528.2010.02540.x. Review.</citation>
    <PMID>20353459</PMID>
  </reference>
  <reference>
    <citation>Tanentsapf I, Heitmann BL, Adegboye AR. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth. 2011 Oct 26;11:81. doi: 10.1186/1471-2393-11-81. Review.</citation>
    <PMID>22029725</PMID>
  </reference>
  <reference>
    <citation>Quinlivan JA, Julania S, Lam L. Antenatal dietary interventions in obese pregnant women to restrict gestational weight gain to Institute of Medicine recommendations: a meta-analysis. Obstet Gynecol. 2011 Dec;118(6):1395-401. doi: 10.1097/AOG.0b013e3182396bc6. Review.</citation>
    <PMID>22105270</PMID>
  </reference>
  <reference>
    <citation>Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, Kunz R, Mol BW, Coomarasamy A, Khan KS. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012 May 16;344:e2088. doi: 10.1136/bmj.e2088.</citation>
    <PMID>22596383</PMID>
  </reference>
  <reference>
    <citation>Thangaratinam S, Jolly K. Obesity in pregnancy: a review of reviews on the effectiveness of interventions. BJOG. 2010 Oct;117(11):1309-12. doi: 10.1111/j.1471-0528.2010.02670.x.</citation>
    <PMID>20862792</PMID>
  </reference>
  <reference>
    <citation>Kiel DW, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007 Oct;110(4):752-8.</citation>
    <PMID>17906005</PMID>
  </reference>
  <reference>
    <citation>Oken E, Kleinman KP, Belfort MB, Hammitt JK, Gillman MW. Associations of gestational weight gain with short- and longer-term maternal and child health outcomes. Am J Epidemiol. 2009 Jul 15;170(2):173-80. doi: 10.1093/aje/kwp101. Epub 2009 May 13.</citation>
    <PMID>19439579</PMID>
  </reference>
  <reference>
    <citation>Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B. Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr. 2010 Jun;91(6):1642-8. doi: 10.3945/ajcn.2009.29008. Epub 2010 Mar 31.</citation>
    <PMID>20357043</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Mele L, Landon MB, Ramin SM, Reddy UM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Saade G, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? Am J Obstet Gynecol. 2014 Aug;211(2):137.e1-7. doi: 10.1016/j.ajog.2014.02.004. Epub 2014 Feb 11.</citation>
    <PMID>24530820</PMID>
  </reference>
  <reference>
    <citation>Wallace JM, Bhattacharya S, Campbell DM, Horgan GW. Inter-pregnancy weight change impacts placental weight and is associated with the risk of adverse pregnancy outcomes in the second pregnancy. BMC Pregnancy Childbirth. 2014 Jan 22;14:40. doi: 10.1186/1471-2393-14-40.</citation>
    <PMID>24450357</PMID>
  </reference>
  <reference>
    <citation>Jain AP, Gavard JA, Rice JJ, Catanzaro RB, Artal R, Hopkins SA. The impact of interpregnancy weight change on birthweight in obese women. Am J Obstet Gynecol. 2013 Mar;208(3):205.e1-7. doi: 10.1016/j.ajog.2012.12.018. Epub 2012 Dec 12.</citation>
    <PMID>23246318</PMID>
  </reference>
  <reference>
    <citation>Ehrlich SF, Hedderson MM, Feng J, Davenport ER, Gunderson EP, Ferrara A. Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet Gynecol. 2011 Jun;117(6):1323-30. doi: 10.1097/AOG.0b013e31821aa358.</citation>
    <PMID>21606742</PMID>
  </reference>
  <reference>
    <citation>Mostello D, Jen Chang J, Allen J, Luehr L, Shyken J, Leet T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol. 2010 Sep;116(3):667-72. doi: 10.1097/AOG.0b013e3181ed74ea.</citation>
    <PMID>20733450</PMID>
  </reference>
  <reference>
    <citation>Getahun D, Ananth CV, Oyelese Y, Chavez MR, Kirby RS, Smulian JC. Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet Gynecol. 2007 Dec;110(6):1319-25.</citation>
    <PMID>18055727</PMID>
  </reference>
  <reference>
    <citation>Bogaerts A, Van den Bergh BR, Ameye L, Witters I, Martens E, Timmerman D, Devlieger R. Interpregnancy weight change and risk for adverse perinatal outcome. Obstet Gynecol. 2013 Nov;122(5):999-1009. doi: 10.1097/AOG.0b013e3182a7f63e.</citation>
    <PMID>24104777</PMID>
  </reference>
  <reference>
    <citation>Glazer NL, Hendrickson AF, Schellenbaum GD, Mueller BA. Weight change and the risk of gestational diabetes in obese women. Epidemiology. 2004 Nov;15(6):733-7.</citation>
    <PMID>15475723</PMID>
  </reference>
  <reference>
    <citation>Lovelady CA, Garner KE, Moreno KL, Williams JP. The effect of weight loss in overweight, lactating women on the growth of their infants. N Engl J Med. 2000 Feb 17;342(7):449-53.</citation>
    <PMID>10675424</PMID>
  </reference>
  <reference>
    <citation>Colleran HL, Lovelady CA. Use of MyPyramid Menu Planner for Moms in a weight-loss intervention during lactation. J Acad Nutr Diet. 2012 Apr;112(4):553-8. doi: 10.1016/j.jand.2011.12.004.</citation>
    <PMID>22709705</PMID>
  </reference>
  <reference>
    <citation>Stendell-Hollis NR, Thompson PA, West JL, Wertheim BC, Thomson CA. A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women. J Womens Health (Larchmt). 2013 Jan;22(1):48-57. doi: 10.1089/jwh.2012.3707. Epub 2012 Dec 31.</citation>
    <PMID>23276189</PMID>
  </reference>
  <reference>
    <citation>O'Toole ML, Sawicki MA, Artal R. Structured diet and physical activity prevent postpartum weight retention. J Womens Health (Larchmt). 2003 Dec;12(10):991-8.</citation>
    <PMID>14709187</PMID>
  </reference>
  <reference>
    <citation>Nascimento SL, Pudwell J, Surita FG, Adamo KB, Smith GN. The effect of physical exercise strategies on weight loss in postpartum women: a systematic review and meta-analysis. Int J Obes (Lond). 2014 May;38(5):626-35. doi: 10.1038/ijo.2013.183. Epub 2013 Sep 19. Review.</citation>
    <PMID>24048142</PMID>
  </reference>
  <reference>
    <citation>Rönö K, Stach-Lempinen B, Klemetti MM, Kaaja RJ, Pöyhönen-Alho M, Eriksson JG, Koivusalo SB; RADIEL group. Prevention of gestational diabetes through lifestyle intervention: study design and methods of a Finnish randomized controlled multicenter trial (RADIEL). BMC Pregnancy Childbirth. 2014 Feb 14;14:70. doi: 10.1186/1471-2393-14-70.</citation>
    <PMID>24524674</PMID>
  </reference>
  <reference>
    <citation>Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006 Sep 30;368(9542):1164-70.</citation>
    <PMID>17011943</PMID>
  </reference>
  <reference>
    <citation>Lassance L, Haghiac M, Leahy P, Basu S, Minium J, Zhou J, Reider M, Catalano PM, Hauguel-de Mouzon S. Identification of early transcriptome signatures in placenta exposed to insulin and obesity. Am J Obstet Gynecol. 2015 May;212(5):647.e1-11. doi: 10.1016/j.ajog.2015.02.026. Epub 2015 Feb 28.</citation>
    <PMID>25731694</PMID>
  </reference>
  <reference>
    <citation>Yassine HN, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):90-5. doi: 10.1093/gerona/gln032. Epub 2009 Jan 20.</citation>
    <PMID>19164269</PMID>
  </reference>
  <reference>
    <citation>Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines; Rasmussen KM, Yaktine AL, editors. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US); 2009.</citation>
    <PMID>20669500</PMID>
  </reference>
  <reference>
    <citation>Resi V, Basu S, Haghiac M, Presley L, Minium J, Kaufman B, Bernard S, Catalano P, Hauguel-de Mouzon S. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E832-40. doi: 10.1152/ajpendo.00002.2012. Epub 2012 Jul 17.</citation>
    <PMID>22811467</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1667-72.</citation>
    <PMID>1750458</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Tyzbir ED, Wolfe RR, Roman NM, Amini SB, Sims EA. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):913-9.</citation>
    <PMID>1415425</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, Sims EA. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993 Jan;264(1 Pt 1):E60-7.</citation>
    <PMID>8430789</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Drago NM, Amini SB. Factors affecting fetal growth and body composition. Am J Obstet Gynecol. 1995 May;172(5):1459-63.</citation>
    <PMID>7755054</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Drago NM, Amini SB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol. 1995 May;172(5):1464-70.</citation>
    <PMID>7755055</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Roman-Drago NM, Amini SB, Sims EA. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol. 1998 Jul;179(1):156-65.</citation>
    <PMID>9704782</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999 Apr;180(4):903-16.</citation>
    <PMID>10203659</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, Friedman JE. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E522-33.</citation>
    <PMID>11832353</PMID>
  </reference>
  <reference>
    <citation>O'Tierney-Ginn P, Presley L, Myers S, Catalano P. Placental growth response to maternal insulin in early pregnancy. J Clin Endocrinol Metab. 2015 Jan;100(1):159-65. doi: 10.1210/jc.2014-3281.</citation>
    <PMID>25365315</PMID>
  </reference>
  <reference>
    <citation>Koontz MB, Gunzler DD, Presley L, Catalano PM. Longitudinal changes in infant body composition: association with childhood obesity. Pediatr Obes. 2014 Dec;9(6):e141-4. doi: 10.1111/ijpo.253. Epub 2014 Sep 30.</citation>
    <PMID>25267097</PMID>
  </reference>
  <reference>
    <citation>Kirwan JP, Varastehpour A, Jing M, Presley L, Shao J, Friedman JE, Catalano PM. Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J Clin Endocrinol Metab. 2004 Sep;89(9):4678-84.</citation>
    <PMID>15356080</PMID>
  </reference>
  <reference>
    <citation>Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes. 2008 Mar;57(3):606-13. Epub 2007 Dec 14.</citation>
    <PMID>18083784</PMID>
  </reference>
  <reference>
    <citation>Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP. Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care. 2010 Jul;33(7):1561-6. doi: 10.2337/dc09-2021. Epub 2010 Mar 3.</citation>
    <PMID>20200305</PMID>
  </reference>
  <reference>
    <citation>Solomon TP, Haus JM, Kelly KR, Cook MD, Filion J, Rocco M, Kashyap SR, Watanabe RM, Barkoukis H, Kirwan JP. A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr. 2010 Dec;92(6):1359-68. doi: 10.3945/ajcn.2010.29771. Epub 2010 Oct 27.</citation>
    <PMID>20980494</PMID>
  </reference>
  <reference>
    <citation>Calabuig-Navarro V, Puchowicz M, Glazebrook P, Haghiac M, Minium J, Catalano P, Hauguel deMouzon S, O'Tierney-Ginn P. Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women. Am J Clin Nutr. 2016 Apr;103(4):1064-72.</citation>
    <PMID>26961929</PMID>
  </reference>
  <reference>
    <citation>Ptomey LT, Willis EA, Honas JJ, Mayo MS, Washburn RA, Herrmann SD, Sullivan DK, Donnelly JE. Validity of energy intake estimated by digital photography plus recall in overweight and obese young adults. J Acad Nutr Diet. 2015 Sep;115(9):1392-9. doi: 10.1016/j.jand.2015.05.006. Epub 2015 Jun 26.</citation>
    <PMID>26122282</PMID>
  </reference>
  <reference>
    <citation>Look AHEAD Research Group, Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006 May;14(5):737-52. Review. Erratum in: Obesity (Silver Spring). 2007 May;15(5):1339. Wadden, Thomas A [added]; West, Delia Smith [added]; Delahanty, Linda [added]; Jakicic, John [added]; Rejeski, Jack [added]; Williamson, Don [added]; Berkowitz, Robert I [added]; Kelley, David E [added]; Tomchee, Christine [added]; Hill, James O [added]; Kumanyika, Shiriki [added].</citation>
    <PMID>16855180</PMID>
  </reference>
  <reference>
    <citation>Donnelly JE, Goetz J, Gibson C, Sullivan DK, Lee R, Smith BK, Lambourne K, Mayo MS, Hunt S, Lee JH, Honas JJ, Washburn RA. Equivalent weight loss for weight management programs delivered by phone and clinic. Obesity (Silver Spring). 2013 Oct;21(10):1951-9. doi: 10.1002/oby.20334. Epub 2013 May 25.</citation>
    <PMID>23408579</PMID>
  </reference>
  <reference>
    <citation>Siri WE. Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition. 1993 Sep-Oct;9(5):480-91; discussion 480, 492.</citation>
    <PMID>8286893</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Wong WW, Drago NM, Amini SB. Estimating body composition in late gestation: a new hydration constant for body density and total body water. Am J Physiol. 1995 Jan;268(1 Pt 1):E153-8.</citation>
    <PMID>7840173</PMID>
  </reference>
  <reference>
    <citation>Sady SP, Carpenter MW, Sady MA, Haydon B, Hoegsberg B, Cullinane EM, Thompson PD, Coustan DR. Prediction of VO2max during cycle exercise in pregnant women. J Appl Physiol (1985). 1988 Aug;65(2):657-61.</citation>
    <PMID>3170418</PMID>
  </reference>
  <reference>
    <citation>Watanabe RM, Steil GM, Bergman RN. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion. Am J Physiol. 1998 Jan;274(1 Pt 1):E172-83.</citation>
    <PMID>9458763</PMID>
  </reference>
  <reference>
    <citation>Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982 Dec 1;144(7):768-73.</citation>
    <PMID>7148898</PMID>
  </reference>
  <reference>
    <citation>Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994 Apr;17(4):267-74.</citation>
    <PMID>8026281</PMID>
  </reference>
  <reference>
    <citation>Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 Nov;51(11):903-12.</citation>
    <PMID>9817107</PMID>
  </reference>
  <reference>
    <citation>Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol. 2006 Oct;195(4):1100-3. Epub 2006 Jul 26.</citation>
    <PMID>16875645</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Tyzbir ED, Allen SR, McBean JH, McAuliffe TL. Evaluation of fetal growth by estimation of neonatal body composition. Obstet Gynecol. 1992 Jan;79(1):46-50.</citation>
    <PMID>1727584</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Thomas AJ, Avallone DA, Amini SB. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol. 1995 Oct;173(4):1176-81.</citation>
    <PMID>7485315</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009 Jun;32(6):1076-80. doi: 10.2337/dc08-2077.</citation>
    <PMID>19460915</PMID>
  </reference>
  <reference>
    <citation>Lindsay CA, Thomas AJ, Catalano PM. The effect of smoking tobacco on neonatal body composition. Am J Obstet Gynecol. 1997 Nov;177(5):1124-8.</citation>
    <PMID>9396906</PMID>
  </reference>
  <reference>
    <citation>Rohl J, Huston-Presley L, Amini S, Stepanchak B, Catalano P. Factors associated with fetal growth and body composition as measured by ultrasound. Am J Obstet Gynecol. 2001 Dec;185(6):1416-20.</citation>
    <PMID>11744918</PMID>
  </reference>
  <reference>
    <citation>Hashimoto K, Wong WW, Thomas AJ, Uvena-Celebrezze J, Huston-Pressley L, Amini SB, Catalano PM. Estimation of neonatal body composition: isotope dilution versus total-body electrical conductivity. Biol Neonate. 2002;81(3):170-5.</citation>
    <PMID>11937722</PMID>
  </reference>
  <reference>
    <citation>Uvena-Celebrezze J, Fung C, Thomas AJ, Hoty A, Huston-Presley L, Amini SB, Catalano PM. Relationship of neonatal body composition to maternal glucose control in women with gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2002 Dec;12(6):396-401.</citation>
    <PMID>12683650</PMID>
  </reference>
  <reference>
    <citation>Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003 Dec;189(6):1698-704.</citation>
    <PMID>14710101</PMID>
  </reference>
  <reference>
    <citation>Durnwald C, Huston-Presley L, Amini S, Catalano P. Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol. 2004 Sep;191(3):804-8.</citation>
    <PMID>15467545</PMID>
  </reference>
  <reference>
    <citation>Singh KA, Huston-Presley LP, Mencin P, Thomas A, Amini SB, Catalano PM. Birth weight and body composition of neonates born to Caucasian compared with African-American mothers. Obstet Gynecol. 2010 May;115(5):998-1002. doi: 10.1097/AOG.0b013e3181da901a.</citation>
    <PMID>20410774</PMID>
  </reference>
  <reference>
    <citation>Waters TP, Huston-Presley L, Catalano PM. Neonatal body composition according to the revised institute of medicine recommendations for maternal weight gain. J Clin Endocrinol Metab. 2012 Oct;97(10):3648-54. doi: 10.1210/jc.2012-1781. Epub 2012 Jul 20.</citation>
    <PMID>22821895</PMID>
  </reference>
  <reference>
    <citation>Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9.</citation>
    <PMID>3899825</PMID>
  </reference>
  <reference>
    <citation>Lassance L, Haghiac M, Minium J, Catalano P, Hauguel-de Mouzon S. Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production. J Clin Endocrinol Metab. 2015 Jan;100(1):E11-8. doi: 10.1210/jc.2014-2792.</citation>
    <PMID>25322273</PMID>
  </reference>
  <reference>
    <citation>Visiedo F, Bugatto F, Sánchez V, Cózar-Castellano I, Bartha JL, Perdomo G. High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Metab. 2013 Jul 15;305(2):E205-12. doi: 10.1152/ajpendo.00032.2013. Epub 2013 May 14.</citation>
    <PMID>23673156</PMID>
  </reference>
  <reference>
    <citation>Brass E, Hanson E, O'Tierney-Ginn PF. Placental oleic acid uptake is lower in male offspring of obese women. Placenta. 2013 Jun;34(6):503-9. doi: 10.1016/j.placenta.2013.03.009. Epub 2013 Apr 17.</citation>
    <PMID>23602336</PMID>
  </reference>
  <reference>
    <citation>Hughes SD, Quaade C, Johnson JH, Ferber S, Newgard CB. Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. J Biol Chem. 1993 Jul 15;268(20):15205-12.</citation>
    <PMID>8325893</PMID>
  </reference>
  <reference>
    <citation>FOLCH J, LEES M, SLOANE STANLEY GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497-509.</citation>
    <PMID>13428781</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2017</study_first_submitted>
  <study_first_submitted_qc>May 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MetroHealth Medical Center</investigator_affiliation>
    <investigator_full_name>Patrick Catalano</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>overweight</keyword>
  <keyword>lifestyle intervention</keyword>
  <keyword>fetal growth/adiposity</keyword>
  <keyword>Mediterranean diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Macrosomia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results of the study will be available in a de-identified manner by contacting the Principal Investigator, after the results have been published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

